COVID-19 Antigen Test Market Report Provides Insights Into Market Evolution And Growth Prospects

The COVID-19 antigen test market is poised for substantial expansion as the global focus on infectious disease management intensifies. Advances in diagnostic technologies and growing public health initiatives are shaping the future landscape of this essential healthcare segment. Let's explore the current market size, key players, emerging trends, and segmentation details that define the COVID-19 antigen test industry.

Steady Growth Expected in the COVID-19 Antigen Test Market Size
The market for COVID-19 antigen tests is projected to reach $10.84 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.4%. This impressive growth is largely driven by enhanced preparedness for future pandemics, the rise of decentralized testing models, increased monitoring of infectious diseases, a higher demand for cost-effective diagnostic tools, and the ongoing integration of these tests with digital health platforms. Important trends anticipated over the forecast period include a wider rollout of rapid point-of-care testing, more widespread use of home testing kits, expanded mass screening initiatives, easier sample collection processes, and stronger connections with public health surveillance systems.

The covid-19 antigen test market size has grown strongly in recent years. It will grow from $7.59 billion in 2025 to $8.14 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to global pandemic outbreak, urgent need for rapid diagnosis, government-led testing initiatives, hospital-based testing reliance, emergency regulatory approvals.

Download a free sample of the covid-19 antigen test market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13410&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Driving Innovation in the COVID-19 Antigen Test Industry
Several prominent organizations dominate the COVID-19 antigen test market, including F. Hoffmann-La Roche AG, Abbott Laboratories, Becton And dic*kinson and Company, Laboratory Corporation Of America, PerkinElmer Inc., Quidel Corporation, SD Biosensor Inc., and Diasorin S.P.A, among others. These companies are continuously advancing their diagnostic offerings to meet global demand and improve testing accuracy and accessibility.

Strategic Acquisitions Strengthen Market Positions
In June 2023, Avacta Group plc, a UK-based diagnostics and therapeutics firm, acquired Coris Bioconcept SRL, a Belgium-based manufacturer specializing in rapid lateral flow test kits for respiratory and other infections. This acquisition allows Avacta to broaden its portfolio of rapid diagnostic tools by incorporating Coris Bioconcept's professional-use lateral flow assays, including COVID-19 antigen tests. Additionally, the deal leverages Coris's established manufacturing and distribution networks throughout Europe and international markets, enhancing Avacta's global reach.

View the full covid-19 antigen test market report:
https://www.thebusinessresearchcompany.com/report/covid-19-antigen-test-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Highlighting Opportunities in the COVID-19 Antigen Test Market
Market leaders are focusing heavily on developing novel solutions such as rapid multiplex at-home antigen tests, which can detect several respiratory pathogens simultaneously. These tests offer a fast, convenient way for users to self-diagnose infections like COVID-19 and influenza from a single sample, supporting early isolation and treatment while alleviating burdens on healthcare systems.

For example, iHealth Inc., a US-based digital health company, launched its 3 in 1 COVID 19/Flu A&B Rapid Test Kit in May 2024. This over-the-counter (OTC) home test delivers results within 15 minutes using an anterior nasal swab. It clearly distinguishes COVID-19, influenza A, and influenza B results through a color-coded readout. Designed for users aged 2 and above (with adult supervision for younger children), it offers rapid and user-friendly self-collection without special skills or equipment. This innovation empowers individuals to quickly assess their health status at home and take timely action.

Market Segmentation Revealing the Largest Shareholders in COVID-19 Antigen Testing
This report categorizes the COVID-19 antigen test market into several key segments:
1) Product and Service types, including Platforms, Reagents and Kits, and Services.
2) Specimen Types, such as Nasopharyngeal Swab, Oropharyngeal Swab, and Nasal Swab.
3) End-Use sectors encompassing Clinics and Hospitals, Home Care, Diagnostic Labs, and Other Applications.

Further subcategories detail Platforms into Lateral Flow and ELISA Platforms; Reagents and Kits divided into Test Kits and Reagents; and Services split between Testing Services and Laboratory Services. This segmentation provides a clear view of where market demand is strongest and how the industry continues to evolve.

Our 2026 market reports now include enhanced strategic insights through:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.